Comprehensive ceRNA network analysis and experimental studies identify an IGF2-AS/miR-150/IGF2 regulatory axis in colorectal cancer.

[1]  S. Wyke,et al.  Why colorectal screening fails to achieve the uptake rates of breast and cervical cancer screening: a comparative qualitative study , 2019, BMJ Quality & Safety.

[2]  C. Ulrich,et al.  Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses , 2019, Gastroenterology.

[3]  Jiangning Chen,et al.  microRNAs as therapeutic targets in intestinal diseases , 2019, ExRNA.

[4]  Yuan Yin,et al.  An Integrated Three-Long Non-coding RNA Signature Predicts Prognosis in Colorectal Cancer Patients , 2019, Front. Oncol..

[5]  R. Dienstmann,et al.  Predictive modeling in colorectal cancer: time to move beyond consensus molecular subtypes. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  S. Vacher,et al.  Interaction between IGF2‐PI3K axis and cancer‐associated‐fibroblasts promotes anal squamous carcinogenesis , 2019, International journal of cancer.

[7]  Hong-Fei Fu,et al.  The roles of small RNAs: insights from bacterial quorum sensing , 2019, ExRNA.

[8]  Ju Huang,et al.  IGF2-AS affects the prognosis and metastasis of gastric adenocarcinoma via acting as a ceRNA of miR-503 to regulate SHOX2 , 2019, Gastric Cancer.

[9]  Z. Stadler,et al.  Immunotherapy in colorectal cancer: rationale, challenges and potential , 2019, Nature Reviews Gastroenterology & Hepatology.

[10]  Yuan Yin,et al.  LncRNA‐SNHG15 enhances cell proliferation in colorectal cancer by inhibiting miR‐338‐3p , 2019, Cancer medicine.

[11]  Yuan Yuan,et al.  Competitive Endogenous RNA (ceRNA) Regulation Network of lncRNA–miRNA–mRNA in Colorectal Carcinogenesis , 2019, Digestive Diseases and Sciences.

[12]  F. Wang,et al.  Long Noncoding RNA IGF2AS is Acting as an Epigenetic Tumor Suppressor in Human Prostate Cancer. , 2019, Urology.

[13]  Yu-qin Pan,et al.  lncRNA SNHG6 regulates EZH2 expression by sponging miR-26a/b and miR-214 in colorectal cancer , 2019, Journal of Hematology & Oncology.

[14]  Wei Zheng,et al.  A 15-lncRNA signature predicts survival and functions as a ceRNA in patients with colorectal cancer , 2018, Cancer management and research.

[15]  R. Amini,et al.  MiR-185 enhances radiosensitivity of colorectal cancer cells by targeting IGF1R and IGF2. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[16]  Yue Zhang,et al.  Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma , 2018, Cellular Physiology and Biochemistry.

[17]  Hong Zhang,et al.  LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway , 2018, Molecular cancer.

[18]  Qing‐Yu He,et al.  IGF2 induces CD133 expression in esophageal cancer cells to promote cancer stemness. , 2018, Cancer letters.

[19]  Yuan Yin,et al.  LncRNA–FEZF1-AS1 Promotes Tumor Proliferation and Metastasis in Colorectal Cancer by Regulating PKM2 Signaling , 2018, Clinical Cancer Research.

[20]  Fenghua Wang,et al.  Long non-coding RNA UICLM promotes colorectal cancer liver metastasis by acting as a ceRNA for microRNA-215 to regulate ZEB2 expression , 2017, Theranostics.

[21]  P. Gao,et al.  Non-coding RNAs participate in the regulatory network of CLDN4 via ceRNA mediated miRNA evasion , 2017, Nature Communications.

[22]  Q. Dong,et al.  Long non-coding RNA Igf2as controls hepatocellular carcinoma progression through the ERK/MAPK signaling pathway , 2017, Oncology letters.

[23]  I. Petersen,et al.  Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking , 2016, Nature Genetics.

[24]  S Miyano,et al.  Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells , 2016, Oncogene.

[25]  Yuan Yin,et al.  LncRNA—UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p , 2016, Scientific Reports.

[26]  Gloria S. Huang,et al.  IGF2 signaling and regulation in cancer. , 2015, Cytokine & growth factor reviews.

[27]  P. Kapranov,et al.  The Landscape of long noncoding RNA classification. , 2015, Trends in genetics : TIG.

[28]  Eugenia G. Giannopoulou,et al.  The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer , 2014, Nature Communications.

[29]  Fang Wang,et al.  Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell‐like property of hepatocellular carcinoma cells by stabilizing NOP2 , 2014, Hepatology.

[30]  Ming Sun,et al.  Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer , 2014, Molecular Cancer.

[31]  P. Pandolfi,et al.  A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language? , 2011, Cell.

[32]  C. Brennan,et al.  Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer , 2010, International journal of cancer.

[33]  L. Matthews,et al.  Conservation of the H19 noncoding RNA and H19-IGF2 imprinting mechanism in therians , 2008, Nature Genetics.

[34]  Howard Y. Chang,et al.  Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs , 2007, Cell.

[35]  A. Feinberg,et al.  Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk , 2003, Science.

[36]  M. Surani,et al.  Expression and imprinting status of human PEG8/IGF2AS, a paternally expressed antisense transcript from the IGF2 locus, in Wilms' tumors. , 2000, Journal of biochemistry.

[37]  Pui Yan Yeung,et al.  Revealing lncRNA Structures and Interactions by Sequencing-Based Approaches. , 2019, TIBS -Trends in Biochemical Sciences. Regular ed.